|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online June 3, 2003 as doi:10.1096/fj.02-0963fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mRNA expression 1
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Luebeck, D-23538 Luebeck, Germany
2Correspondence: Institute of Experimental and Clinical Pharmacology and Toxicology, University Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany. E-mail: heidbred{at}medinf.mu-luebeck.de
SPECIFIC AIMS
Although the pivotal role of the transcriptional complex hypoxia-inducible factor 1 (HIF-1) for protection against hypoxia is well documented, the expression patterns and functional properties of HIF-2
and HIF-3
remain to be elucidated. The present study addressed early in vivo changes of expression of HIF-1
, HIF-1ß, HIF-2
,, and HIF-3
during moderate hypoxic conditions and their correlation with the expression of the HIF target genes erythropoietin (EPO) and glucose transporter 1 (GLUT1).
PRINCIPAL FINDINGS
1. HIF-1
, HIF-1ß, HIF-2
, and HIF-3
are expressed during normal O2 tensions in an organ-dependent manner
By quantitative real-time RT-PCR and immunoblotting, physiological levels of expression of HIF-1
, HIF-1ß, HIF-2
, and HIF-3
were determined in cerebral cortex, hippocampus, lung, heart, liver, and kidney. Distinct mRNA levels of all HIF subunits were detectable in these tissues during normoxia whereby the amounts of mRNA appeared to differ in an organ-specific fashion (Fig. 1
AD). The cerebral cortex, hippocampus, and lung featured highest mRNA levels regarding all HIF subunits. In lung tissue, abundant amounts of all HIF mRNAs were present. In contrast, myocardial tissue and the liver contained minor amounts of all HIF subunits mRNAs. Referring to the absolute numbers of HIF-1
, HIF-1ß, and HIF-2
, all examined organs yielded HIF-3
-specific mRNA amounts less than the other subunits.
|
The mRNA expression patterns were paralleled by results of immunoblots, where even in normoxia a clear presence of all HIF proteins in the brain and the lung became visible. In heart, liver, and kidney, HIF-1
, HIF-1ß, HIF-2
, and HIF-3
proteins were not detectable (data not shown).
2. Moderate hypoxia is capable of activation of the HIF target genes EPO and GLUT1
Healthy male Wistar rats were exposed to half of normal O2 tensions (65 mmHg) for intervals of 0.5 or 2 h. In contrast to earlier studies that applied severe and/or long-lasting hypoxia either in vivo or in cell culture experiments, we simulated a more physiological in vivo situation using O2 tensions that corresponded to values observable in pulmonary diseases. GLUT1 and EPO were chosen as established target genes of HIF to reflect the extent of activation during this moderate hypoxia. EPO mRNA was not detectable during normoxic conditions apart from the kidney, where low mRNA amounts were observed. As expected, a pronounced increase of EPO mRNA occurred in the kidney after 2 h of hypoxia. In contrast, GLUT1 mRNA was already traceable in normoxic animals. High amounts of GLUT1 mRNA were present in cerebral cortex, hippocampus, and lung. When hypoxia was terminated after 2 h, a rise of GLUT1 mRNA was observable in all organs and was significant in cerebral cortex, hippocampus, liver, and kidney.
3. Moderate hypoxia causes a rapid increase of HIF-3
mRNA transcripts
Regarding mRNA levels of HIF-1
, HIF-1ß, and HIF-2
, no significant changes of mRNA amounts were observed during hypoxia (Fig. 2
AC). HIF-3
presented a completely different expression pattern. Levels of HIF-3
mRNA rose significantly with the duration of systemic hypoxia (Fig. 2
D). This increase was not restricted to specific organs; rather, it occurred in all tissues examined with exception of the liver. Here, HIF-3
mRNA levels showed a trend to increase (150%) that was not significant. In contrast, marked up-regulation occurred in the cortex (430%), hippocampus (630%), lung (460%), kidney (720%), and myocardial tissue (690%).
|
CONCLUSIONS AND SIGNIFICANCE
The results of this study clearly demonstrate the presence of HIF-1
, HIF-1ß, HIF-2
, and HIF-3
during normoxic conditions in all tissues examined, indicating a constitutive expression. This is in line with the suggestion that HIF-1
and HIF-1ß are kept at a certain level of expression that is necessary to maintain target gene transcription for physiological basal energy homeostasis; based on our results, this function may also apply to HIF-2
and HIF-3
. The amounts of the various HIF mRNAs depended on the type of tissue. High steady-state mRNA levels of all HIF subunits were determined in brain tissue and the lung, implicating an organ-specific priority that is high in these organs and lower in heart and liver, proposing that in latter organs other or additional mechanisms of protection against hypoxic damage are active. The high priority of brain and lung in the oxygen supply hierarchy is supported by the fact that patterns of GLUT-1 mRNA distribution were similar to that obtained for the various HIF subunits. The highest baseline amounts of mRNA encoding for GLUT1 were again detected in cortex, hippocampus, and lung. GLUT-1 mRNA increased after 30 min of moderate hypoxia and reached significant peaks in the cortex, hippocampus, and liver at the end of 2 h of hypoxia, indicating an efficient activation of the HIF system.
During normoxia, EPO mRNA was traceable only in the kidney and remained undetectable in all other organs during hypoxia. In the kidney, the increase of EPO mRNA after 2 h hypoxia again indicated a sufficient activation by moderate hypoxia. This pattern of activation may point to a sequential activation of the numerous target genes of the HIF system during hypoxia depending on duration and severity of hypoxia.
HIF-1
, HIF-1ß, and HIF-2
mRNA levels were not affected by moderate hypoxia, presumably because the hypoxic protocol we used was not severe enough or the interval too short to induce changes of mRNA content of these subunits. In contrast, a significant increase of mRNA encoding HIF-3
came about not only in the brain, but in all other peripheral tissues. The moderate decrease in O2 tension as used in our model was therefore sufficient to induce HIF-3
mRNA synthesis. At this time, a role of HIF-3
in cellular response to tissue hypoxia has not yet been established in detail. The present immunoblotting results indicate that HIF-3
protein amounts are increasing during hypoxia, denoting a role for this subunit in hypoxia. Despite the structural similarities of HIF-3
to other
-class subunits, HIF-3
clearly is regulated in a different manner. It may be possible that this subunit constitutes a more rapidly reacting component of the response to tissue hypoxia or that HIF-3
responds in a more sensitive way than HIF-1
or HIF-2
(see Fig. 3
). HIF-3
may also be capable of inducing target genes like EPO and GLUT-1, especially in early phases of tissue adaption to low O2 tensions. The precise regulation of HIF-3
in hypoxia and its potential importance in pathophysiological conditions other than hypoxia have to be determined in further studies.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.02-0963fje; doi: 10.1096/fj.02-0963fje ![]()
This article has been cited by other articles:
![]() |
B. Heidecker, E. K. Kasper, I. S. Wittstein, H. C. Champion, E. Breton, S. D. Russell, M. M. Kittleson, K. L. Baughman, and J. M. Hare Transcriptomic Biomarkers for Individual Risk Assessment in New-Onset Heart Failure Circulation, July 15, 2008; 118(3): 238 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chavez, O. Baranova, J. Lin, and P. Pichiule The Transcriptional Activator Hypoxia Inducible Factor 2 (HIF-2/EPAS-1) Regulates the Oxygen-Dependent Expression of Erythropoietin in Cortical Astrocytes J. Neurosci., September 13, 2006; 26(37): 9471 - 9481. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, O. W. Moe, J. A. Garcia, and C. C. W. Hsia Regulated expression of hypoxia-inducible factors during postnatal and postpneumonectomy lung growth Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L880 - L889. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. J. Buermans, E. M. Redout, A. E. Schiel, R. J. P. Musters, M. Zuidwijk, P. P. Eijk, C. van Hardeveld, S. Kasanmoentalib, F. C. Visser, B. Ylstra, et al. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure Physiol Genomics, May 11, 2005; 21(3): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saretzki, L. Armstrong, A. Leake, M. Lako, and T. von Zglinicki Stress Defense in Murine Embryonic Stem Cells Is Superior to That of Various Differentiated Murine Cells Stem Cells, November 1, 2004; 22(6): 962 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Bogoyevitch An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection Cardiovasc Res, August 1, 2004; 63(2): 208 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uchida, F. Rossignol, M. A. Matthay, R. Mounier, S. Couette, E. Clottes, and C. Clerici Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1{alpha} and HIF-2{alpha} Expression in Lung Epithelial Cells: IMPLICATION OF NATURAL ANTISENSE HIF-1{alpha} J. Biol. Chem., April 9, 2004; 279(15): 14871 - 14878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Forkel, X. Chen, S. Wandinger, F. Keser, A. Duschin, U. Schwanke, S. Frede, P. Massoudy, R. Schulz, H. Jakob, et al. Responses of chronically hypoxic rat hearts to ischemia: KATP channel blockade does not abolish increased RV tolerance to ischemia Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H545 - H551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Bruick Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor Genes & Dev., November 1, 2003; 17(21): 2614 - 2623. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |